Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04673032 · ClinicalTrials.gov registry record

Radiofrequency (RF) Ablation Prospective Outcomes Study

A clinical trial of Pain, Chronic, sponsored by Boston Scientific Corporation.

Completed
Registry status
298
Enrollment target
15
Study locations

NCT04673032 is a study of Pain, Chronic that has completed, run by Boston Scientific Corporation. The registered enrollment target is 298 participants, below the 715-participant average among 48 other Pain, Chronic trials with a reported enrollment target (58% lower). The trial reports 15 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04673032, a study of Pain, Chronic, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
298 participants
Enrollment target
15
Study locations

Study Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Conditions Studied

Interventions

  • DEVICE Radiofrequency Ablation

Study Locations (15)

Other

  • ZNA Hoge Beuken - Antwerp
  • St. Jan - Bruges
  • Mater Olbia Hospital - Olbia
  • St. Anna Hospital - Geldrop

Ohio

  • UC Health Pain Medicine - Cincinnati
  • Premier Pain Treatment Institute - Loveland
  • Toledo Clinic - Toledo

Arizona

  • Elite Pain and Spine Institute - Mesa
  • Tucson Orthopaedic Institute - Tucson

Connecticut

  • The Spine Wellness Center in Westport - Westport

Georgia

  • Shepherd Center - Atlanta

Illinois

  • Quincy Medical Group - Quincy

Minnesota

  • Twin Cities Pain Clinic and Surgery Center - Edina

North Carolina

  • Carolinas Research Institute - Huntersville

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2020-12-22
Est. Completion 2025-02-07

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT04673032

The ClinicalTrials.gov registry entry for NCT04673032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 715-participant average among 48 other Pain, Chronic trials with a reported enrollment target (58% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation is the first listed.

NCT04673032 reports 15 study locations spanning 9 distinct geographic areas - top geographies include Other, Ohio, Arizona.

Frequently Asked Questions

What is clinical trial NCT04673032 about?

NCT04673032 is a clinical study titled "Radiofrequency (RF) Ablation Prospective Outcomes Study". The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

What is the current status of trial NCT04673032?

This trial is currently completed. The enrollment target is 298 participants. The study started on 2020-12-22. Estimated completion is 2025-02-07.

What conditions does trial NCT04673032 study?

This clinical trial studies the following conditions: Pain, Chronic.

What interventions are being tested in trial NCT04673032?

The interventions under investigation include: Radiofrequency Ablation (DEVICE).

Who is sponsoring clinical trial NCT04673032?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04673032 being conducted?

This trial has 15 study locations across Arizona, Connecticut, Georgia, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.